ATE403443T1 - Kosmid-dns-konstrukte und verfahren für deren herstellung und verwendung - Google Patents
Kosmid-dns-konstrukte und verfahren für deren herstellung und verwendungInfo
- Publication number
- ATE403443T1 ATE403443T1 AT00986704T AT00986704T ATE403443T1 AT E403443 T1 ATE403443 T1 AT E403443T1 AT 00986704 T AT00986704 T AT 00986704T AT 00986704 T AT00986704 T AT 00986704T AT E403443 T1 ATE403443 T1 AT E403443T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- production
- disclosed
- kosmid
- dns
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000009395 genetic defect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17154199P | 1999-12-22 | 1999-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE403443T1 true ATE403443T1 (de) | 2008-08-15 |
Family
ID=22624126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00986704T ATE403443T1 (de) | 1999-12-22 | 2000-12-22 | Kosmid-dns-konstrukte und verfahren für deren herstellung und verwendung |
Country Status (13)
Country | Link |
---|---|
US (1) | US8529884B2 (de) |
EP (1) | EP1257298B1 (de) |
JP (1) | JP2003518076A (de) |
KR (1) | KR100863823B1 (de) |
CN (1) | CN1414864A (de) |
AT (1) | ATE403443T1 (de) |
AU (1) | AU781724B2 (de) |
BR (1) | BR0016593A (de) |
CA (1) | CA2395435A1 (de) |
DE (1) | DE60039786D1 (de) |
IL (1) | IL150358A0 (de) |
MX (1) | MXPA02006279A (de) |
WO (1) | WO2001045749A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7769599B2 (en) | 2006-07-31 | 2010-08-03 | Visa U.S.A. Inc. | Electronic payment delivery service |
EP3412308A4 (de) * | 2016-02-02 | 2020-02-26 | Nitto Denko Corporation | Zusammensetzung zur förderung der immunitätsinduktion und pharmazeutische impfstoffzusammensetzung |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4481189A (en) * | 1982-04-14 | 1984-11-06 | New York Blood Center Inc. | Process for preparing sterilized plasma and plasma derivatives |
US4591505A (en) * | 1982-04-14 | 1986-05-27 | New York Blood Center, Inc. | Process for inactivating hepatitis B virus |
US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
US4746539A (en) * | 1983-11-23 | 1988-05-24 | The Ohio State University Research Foundation | Purification of cancer-associated protein and preparation of antibody thereto |
US5036006A (en) | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
US4895558A (en) * | 1985-07-15 | 1990-01-23 | University Of Queensland | Autologous plasma delipidation using a continuous flow system |
US4909940A (en) * | 1987-12-30 | 1990-03-20 | New York Blood Center, Inc. | Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons |
US5484396A (en) * | 1988-11-17 | 1996-01-16 | Naficy; Sadeque S. | Method and device for treatment of HIV infections and AIDS |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
EP0465529B1 (de) | 1989-03-21 | 1998-04-29 | Vical, Inc. | Expression von exogenen polynukleotidsequenzen in wirbeltieren |
WO1993023552A1 (en) | 1992-05-21 | 1993-11-25 | Government Of The United States As Represented By Secretary Department Of Health And Human Services | Targeting gene expression to living tissue using jet injection |
NZ262582A (en) | 1993-01-26 | 1997-10-24 | David B Weiner | Compositions and methods for delivery of genetic material |
US5981505A (en) | 1993-01-26 | 1999-11-09 | The Trustees Of The University Of Pennsylvania | Compositions and methods for delivery of genetic material |
US5593972A (en) * | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
EP0710126B1 (de) * | 1993-07-30 | 2004-05-06 | Aruba International Pty. Ltd. | Plasmadelipidationssystem |
US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
US5837533A (en) | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
US5736388A (en) * | 1994-12-30 | 1998-04-07 | Chada; Sunil | Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells |
US5962428A (en) | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
US5703057A (en) * | 1995-04-07 | 1997-12-30 | Board Of Regents The University Of Texas System | Expression library immunization |
US6348353B1 (en) | 1995-06-07 | 2002-02-19 | Case Western Reserve University | Artificial mammalian chromosome |
US5911698A (en) * | 1995-12-22 | 1999-06-15 | Aruba International Pty. Ltd. | Treatment for cardiovascular and related diseases |
US6025155A (en) | 1996-04-10 | 2000-02-15 | Chromos Molecular Systems, Inc. | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
AU3210997A (en) * | 1996-05-24 | 1997-12-09 | University Of Maryland At Baltimore | Dna vaccines for eliciting a mucosal immune response |
WO1998055627A1 (fr) * | 1997-06-04 | 1998-12-10 | The Research Foundation For Microbial Diseases Of Osaka University | Antigenes mutants du virus de la rougeole et genes les codant |
EP1153136A2 (de) * | 1998-12-09 | 2001-11-14 | The General Hospital Corporation | Verbessertes verpacken von hsv-amplikons und herstellung von rekombinanten viralen vektoren |
WO2001032221A1 (en) * | 1999-11-03 | 2001-05-10 | Powderject Vaccines, Inc. | Dna-vaccines based on constructs derived from the genomes of human and animal pathogens |
-
2000
- 2000-12-22 DE DE60039786T patent/DE60039786D1/de not_active Expired - Lifetime
- 2000-12-22 IL IL15035800A patent/IL150358A0/xx unknown
- 2000-12-22 KR KR1020027007987A patent/KR100863823B1/ko not_active IP Right Cessation
- 2000-12-22 US US10/168,694 patent/US8529884B2/en active Active
- 2000-12-22 JP JP2001546688A patent/JP2003518076A/ja active Pending
- 2000-12-22 CN CN00817632A patent/CN1414864A/zh active Pending
- 2000-12-22 BR BR0016593A patent/BR0016593A/pt not_active Application Discontinuation
- 2000-12-22 AT AT00986704T patent/ATE403443T1/de not_active IP Right Cessation
- 2000-12-22 WO PCT/US2000/035033 patent/WO2001045749A1/en active IP Right Grant
- 2000-12-22 MX MXPA02006279A patent/MXPA02006279A/es active IP Right Grant
- 2000-12-22 EP EP00986704A patent/EP1257298B1/de not_active Expired - Lifetime
- 2000-12-22 CA CA 2395435 patent/CA2395435A1/en not_active Abandoned
- 2000-12-22 AU AU22895/01A patent/AU781724B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
MXPA02006279A (es) | 2004-02-26 |
KR20030076217A (ko) | 2003-09-26 |
AU2289501A (en) | 2001-07-03 |
EP1257298A4 (de) | 2004-12-08 |
US8529884B2 (en) | 2013-09-10 |
KR100863823B1 (ko) | 2008-10-15 |
EP1257298B1 (de) | 2008-08-06 |
IL150358A0 (en) | 2002-12-01 |
AU781724B2 (en) | 2005-06-09 |
CN1414864A (zh) | 2003-04-30 |
BR0016593A (pt) | 2002-12-03 |
CA2395435A1 (en) | 2001-06-28 |
JP2003518076A (ja) | 2003-06-03 |
EP1257298A1 (de) | 2002-11-20 |
WO2001045749A1 (en) | 2001-06-28 |
DE60039786D1 (de) | 2008-09-18 |
US20080219953A1 (en) | 2008-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200002973T2 (tr) | Isı şoku proteinlerini kullanarak enflamatuar hastalıkların tedavi edilmesi | |
CY1107453T1 (el) | Baff, σχετικοι δεσμευτικοι παραγοντες και χρηση αυτων στη διεγερση και αναστολη β-κυτταρων και ανοσοσφαιρινων σε ανοσοαποκρισεις | |
DE69938302D1 (de) | Neisseria meningitidis antigene und zusammenstellungen | |
IS6667A (is) | Aðferðir til að meðhöndla gigtarsjúkdóma með því að nota leysanlega CTLA4 sameind | |
BG104236A (en) | Transgenous mammals producing oligosaccharides in their milk | |
NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
DE69929232D1 (de) | Virusähnliche partikel zur induktion von autoantikörpern | |
ATE286053T1 (de) | Naphthyridinone zur hemmung der durch protein- tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung | |
WO2003103586A3 (en) | METHOD OF TREATING AUTOIMMUNE OR INFLAMMATORY DISEASES USING COMBINATIONS OF INHIBITOR OLIGONUCLEOTIDES AND SMALL IMMUNOSTIMULATORY NUCLEIC ACID ANTAGONIST MOLECULES | |
PT721449E (pt) | Inibidores da producao da proteina beta-amiloide | |
DE69635550D1 (de) | Verfahren und mittel zur anregung des neuritwachstums | |
DE69830336D1 (de) | Ein kovalentes konjugat von clozapine und einer fettsäure und dessen verwendung zur behandlung von schizophrenie | |
DE69824597D1 (de) | Ikk-beta proteine, nukleinsäuren und verfahren | |
DE69939312D1 (de) | Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen | |
MX2009006685A (es) | Antagonistas del dr6 y usos de los mismos en el tratamiento de trastornos neurologicos. | |
NO965123D0 (no) | Pantropiske, neurotrofiske faktorer | |
BRPI0515604A (pt) | método para o tratamento de células de cáncer e método de tratamento de uma doença imune relacionada | |
DE602005019626D1 (de) | Zwischenprodukt und verfahren zur herstellung von an beta-anomeren angereicherten 2'-desoxy,2',2'-difluor-d-ribufuranosylnukleosiden | |
ATE505192T1 (de) | Pharmazeutische zusammensetzung zur anwendung in der behandlung von personen mit mutant-kit- protein | |
ATE543833T1 (de) | Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen | |
DE60102147D1 (de) | Anti-gefrier proteine, deren herstellung und verwendung | |
ATE403443T1 (de) | Kosmid-dns-konstrukte und verfahren für deren herstellung und verwendung | |
DK1373502T3 (da) | Dopaminerge neuronale overlevelsesfremmende faktorer og avendelser heraf | |
EP2290077A3 (de) | Natürliche IgM-Antikörper und Inhibitoren | |
PT782630E (pt) | Gene da doenca poliquistica do rim |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |